Vanderbilt Institute for Infection Immunology and Inflammation (VI4) Archive — Page 2 of 5

color-enhanced cross section of tumor tissue
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

By Tom Wilemon
Colorized scanning electron micrograph showing clusters of gold, spherical Staphylococcus aureus bacteria interacting with a red human neutrophil against a dark background.
September 4, 2024

Bacterial metabolism plays role in staph antibiotic tolerance

Staph is a leading bacterial cause of death from bloodstream, bone and joint infections, in part because of high rates of antibiotic treatment failure.

By Leigh MacMillan
Cover of the VI4 AiR (Artist-in-Residence) 2022 annual report: B cells, antibodies and strands of free-flowing DNA represent B cell genome modification and the formation of unique antibodies. Illustration by Nadia Kafil, a UT-Austin biochemistry major who participated in the nationwide AiR program in the lab of Columbia University professor Uttiya Basu, PhD.
July 5, 2024

Vanderbilt Vaccine Center to begin artist-in-residence program this fall

The six-month-long “Visualizing Virology” residency is an extension of the VI4 Artist-in-Residence Program established in 2019 by the Vanderbilt Institute for Infection, Immunology and Inflammation (VI4), and supported by the Burroughs Wellcome Fund.

By Bill Snyder
Modern laboratory with long workbenches, stools, overhead shelving, electrical equipment, and mobile storage cabinets.
January 29, 2024

Expanded space boosts cutting-edge research in infectious diseases and immunology

The Vanderbilt Institute for Infection, Immunology and Inflammation recently debuted state-of-the-art new facilities in Medical Center.

By Leigh MacMillan
Light Hall gallery corridor displaying the “Molecular Muse: V14 & Ariblab Exhibition” poster and abstract artworks above lounge seating. The poster includes dense explanatory text that is too small to read.
January 16, 2024

‘Molecular Muse’ exhibit features Artist-in-Residence program’s science-inspired art

The “Molecular Muse” art exhibit on display in Light Hall is a sampling of pieces from the Vanderbilt Institute for Infection, Immunology and Inflammation Artist-in-Residence (VI4-AiR) program, which brings together scientists and artists to create and promote art as a visual science communication tool.

By Leigh MacMillan
T cells (orange) engage with cancer cells (blue). Halle Borowski, an artist and senior at the College of William and Mary, worked with Drs. Mary Philip and Jess Roetman to create this oil painting, inspired by their research, as part of the Vanderbilt Institute for Infection, Immunology, and Inflammation (VI4) Artist-in-Residence program (https://www.artlab-air.com/).
November 17, 2023

Tumor antigens key to improving cancer immunotherapy: study

An undergraduate artist worked with the Vanderbilt researchers to create this oil painting, inspired the research. They are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients.

By Bill Snyder